Aastrom Biosciences, Inc. (ASTM) Announces Appointment Of Gerard Michel As Chief Financial Officer And Vice President, Corporate Development
6/4/2014 8:56:00 AM
ANN ARBOR, Mich., June 4, 2014 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the appointment of Gerard Michel, MS, MBA, as chief financial officer and vice president, corporate development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by